1982
DOI: 10.1111/j.1346-8138.1982.tb02599.x
|View full text |Cite
|
Sign up to set email alerts
|

Chemoimmunotherapy for Disseminated Malignant Melanoma With Dtic, Acnu, VCR and Ok432

Abstract: Three out of fifteen cases of disseminated malignant melanoma with complete or partial responses to our combined chemoimmunotherapy, DTIC, ACNU, VCR and OK432, are reported. Case 1 responded completely with disappearance of skin and brain lesions. Case 2 responded partially to a lung metastasis. Case 3 responded totally with the complete disappearance of lung and brain metastatic lesions. None of these cases suffered any significant side effects during the trial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1984
1984
2003
2003

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…16) Chemoimmunotherapy using dacarbazine and vincristine with OK432 was effective in the treatment of metastatic malignant melanoma of the brain. 4) Therefore, we administered dacarbazine, the most common chemotherapeutic agent currently used for melanoma, in combination with cisplatin, vindesine, and interferon-b every other month according to the treatment regimen for advanced malignant melanoma. 18,24) Eleven courses of this chemoimmunotherapy were administered.…”
Section: Discussionmentioning
confidence: 99%
“…16) Chemoimmunotherapy using dacarbazine and vincristine with OK432 was effective in the treatment of metastatic malignant melanoma of the brain. 4) Therefore, we administered dacarbazine, the most common chemotherapeutic agent currently used for melanoma, in combination with cisplatin, vindesine, and interferon-b every other month according to the treatment regimen for advanced malignant melanoma. 18,24) Eleven courses of this chemoimmunotherapy were administered.…”
Section: Discussionmentioning
confidence: 99%
“…Chiba et al used this agent in combination with cytostatics in metastasizing melanoma. In a treatment of 15 patients, two achieved a complete and one a partial regres sion [20]. In an adjuvant setting, Hayasaka combined this substance with DTIC (Dacarbacin) and compared it to a group treated only with DTIC.…”
Section: Discussionmentioning
confidence: 99%